Pipeline & Programs

Evox is leveraging the unique inherent abilities of exosomes, namely to efficiently deliver therapeutic cargo, target hard-to-reach tissues and organs, and modulate the immune system. Accordingly, Evox’s development pipeline is focused on inflammatory and immunologically driven diseases, neuroscience, and on various rare diseases with significant unmet medical need. Harnessing its comprehensive technology platform, Evox is working on lead programs focusing on delivery of both protein biologics and nucleic acid-based drugs.